← Back to list
Axial Lumbar Interbody Fusion (AxiaLIF) (CPB 0772, reviewed 2026-10-27)
Effective date
Not stated in the notice
Identified
Nov 2, 2026
Summary
Aetna classifies Axial Lumbar Interbody Fusion (AxiaLIF) using CPT 22586 as experimental, investigational, or unproven for all indications. The practice must stop billing this procedure for Aetna members, obtain prior authorization if a patient elects the procedure anyway, and ensure informed consent documentation is in place.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.
Get Aetna alertsPolicy Monitoring is free. No card required.
What to do
Action · 5 steps
01Confirm the practice has stopped scheduling and billing CPT 22586 (Arthrodesis, pre-sacral interbody technique, L5-S1 interspace) for Aetna members.
02If a patient or provider requests AxiaLIF despite the non-coverage determination, obtain prior authorization from Aetna before proceeding.
03Document the patient's informed consent that the procedure is considered experimental and not covered by their plan.
04Update charge entry and scheduling systems to flag CPT 22586 for Aetna as requiring prior authorization and to track non-coverage status.
05Notify providers and surgical scheduling staff that AxiaLIF is not a covered service under this Aetna policy.
Codes mentioned
22586
Original notice
Axial Lumbar Interbody Fusion (AxiaLIF) (CPB 0772, reviewed 2026-10-27)
aetna.com · Always check the source before changing claims.